secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K/A
Filed at:   2024-01-24T23:59:59+00:00
Accession:  0001193125-24-013513
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica corrects private placement terms; raises up to ~$55M for clinical trials
--------------------------------------------------------------------------------

- Corrected offering: 4,985,610 shares, 306,506 pre-funded warrants, 5,292,116 common warrants at $3.827/unit.
- Upfront gross proceeds $20.4M; potential $33.1M from warrant exercise for total ~$54M (press release: ~$55M).
- Preliminary cash Dec 31, 2023: $11.2M; net proceeds to fund Phase 2 trials of Auxora in AP and AKI.
- New investors include Deerfield affiliate, Soleus Capital, Stonepine, Aisling; existing Sanderling and Bering participated.
- Tranche A warrants ($5.36) expire Dec 31, 2024 or 30 days after AP topline; Tranche B ($7.15) expire Dec 31, 2026 or after AKI topline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312524013513/0001193125-24-013513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312524013513/d738337d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-013513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer